STOCK TITAN
  1. Home
  2. Sec-filings
  3. DERM
  4. [EFFECT] Journey Medical Corp SEC Filing

[EFFECT] Journey Medical Corp SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 21, 2026 9:00 A.M.
Form: S-3
CIK: 0001867066
Company Name: Journey Medical Corp
File Number: 333-292758

Source: View Original Filing on SEC EDGAR

Journey Medical Corp

NASDAQ:DERM

View DERM Stock Overview →

DERM Rankings

#4207 Ranked by Market Cap
N/A Ranked by Dividends

DERM Latest News

Dec 10, 2025
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Nov 12, 2025
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Nov 5, 2025
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Oct 24, 2025
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
Oct 8, 2025
Journey Medical Corporation to Participate in October 2025 Investor Conferences

DERM Latest SEC Filings

Jan 23, 2026
[424B3] Journey Medical Corp Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 23, 2026
[424B3] Journey Medical Corp Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 15, 2026
[S-3] Journey Medical Corp Shelf Registration Statement
Nov 12, 2025
[8-K] Journey Medical Corp Reports Material Event
Nov 12, 2025
[10-Q] Journey Medical Corp Quarterly Earnings Report

DERM Stock Data

266.72M
26.39M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SCOTTSDALE